NAT10-Driven ac4C RNA Modification Regulates Oocyte Maturation

Study Background and Research Question

Oocyte maturation is a tightly regulated process essential for successful fertilization and embryo development. In mammals, oocytes remain arrested at the germinal vesicle (GV) stage until hormonal cues trigger the progression of meiosis. Notably, this maturation process is predominantly governed by post-transcriptional mechanisms, as oocytes accumulate their maternal mRNA prior to meiotic resumption and cease active transcription at the GV stage. Consequently, the stability and translational availability of these mRNAs are critical determinants for developmental competence, yet the regulatory landscape remains incompletely defined.

Epigenetic modifications of RNA—including N6-methyladenosine (m6A) and the more recently characterized N4-acetylcytidine (ac4C)—have emerged as key modulators of mRNA fate, impacting stability, splicing, localization, and translation. The reference study (Xiang et al., 2021) investigates whether NAT10-mediated ac4C modification plays a functional role during the in vitro maturation (IVM) of mouse oocytes, with a focus on its regulatory impact on meiotic progression and mRNA dynamics.

Key Innovation from the Reference Study

The central innovation of this study lies in mapping the dynamics and functional consequences of ac4C RNA modification during mammalian oocyte maturation. Unlike better-studied mRNA modifications, such as m6A, the biological relevance of ac4C in gametogenesis was previously unexplored. By demonstrating that NAT10—the only known mammalian ac4C writer enzyme—is downregulated during oocyte maturation and that its depletion impairs progression beyond the GV stage, this work introduces ac4C as a critical regulatory mark in reproductive cell biology. Furthermore, the identification of TBL3 as a candidate ac4C-binding protein opens new avenues for understanding post-transcriptional control in early development.

Methods and Experimental Design Insights

The authors employed a combination of molecular, cellular, and bioinformatics approaches to dissect the role of NAT10 and ac4C during oocyte IVM. Key methodological highlights include:

• Measurement of NAT10 and ac4C levels in mouse oocytes at different maturation stages using immunofluorescence and quantitative analyses.
• Knockdown of NAT10 expression in GV-stage oocytes via targeted small interfering RNA (siRNA) microinjection, followed by in vitro culture to assess meiotic progression.
• Quantification of meiotic markers, specifically rates of germinal vesicle breakdown (GVBD) and first polar body extrusion, to determine the impact on maturation efficiency.
• RNA immunoprecipitation and high-throughput sequencing in HEK293T cells to identify transcriptomic changes and pathways affected by altered ac4C modification.
• Bioinformatics prediction and experimental validation of ac4C-interacting proteins, with subsequent RNA pulldown assays to probe protein–RNA interactions.

Protocol Parameters

• siRNA delivery: Microinject NAT10-targeting siRNA into GV-stage mouse oocytes prior to IVM culture.
• IVM conditions: Culture oocytes in standard maturation medium and monitor for GVBD and polar body extrusion over 16–24 hours.
• Immunostaining: Apply anti-ac4C and anti-NAT10 antibodies to fixed oocytes at designated time points for fluorescence quantification.
• RNA immunoprecipitation: Use ac4C-specific antibodies to pull down modified transcripts from cell lysates, followed by deep sequencing.
• Protein–RNA interaction assays: Perform RNA pulldown using candidate ac4C-binding proteins (e.g., TBL3) and assess via western blot or mass spectrometry.

Core Findings and Why They Matter

Key results from the study include:

• Downregulation of ac4C and NAT10 during maturation: Both ac4C modification and NAT10 expression decrease from the GV to metaphase II (MII) stages, indicating dynamic regulation during oocyte maturation.
• NAT10 knockdown impairs meiotic progression: Oocytes with reduced NAT10 expression show significantly lower rates of first polar body extrusion (34.6%, versus ~74% in controls), while GVBD rates are unaffected (Xiang et al., 2021). This suggests a role for ac4C in the later steps of meiosis rather than initial meiotic resumption.
• Transcriptomic effects: NAT10 knockdown alters the expression of genes enriched in chromatin remodeling, cytoskeletal anchoring, and epigenetic silencing pathways, consistent with a broader influence of ac4C on post-transcriptional gene regulation.
• Potential ac4C reader identification: Bioinformatic and pulldown analyses nominate TBL3 as a candidate ac4C-binding protein, suggesting a mechanism by which ac4C-modified RNAs may exert functional effects during maturation.

Collectively, these findings position ac4C as a previously unappreciated post-transcriptional regulator in oocyte biology. The data also highlight the specificity of ac4C-mediated control, as early meiotic events (GVBD) are unaffected, whereas later progression (polar body extrusion) is acutely sensitive to loss of ac4C.

Comparison with Existing Internal Articles

Several internal resources expand on the functional and methodological landscape described in the reference study. The article "NAT10-Driven ac4C RNA Modification Regulates Mouse Oocyte Maturation" provides a mechanistic summary congruent with the primary findings here, emphasizing ac4C’s regulatory impact on meiotic progression and developmental competence. Meanwhile, "From Mechanism to Medicine: Strategic Advances in Transla..." situates NAT10 and ac4C within the broader context of RNA epigenetics and translational research, highlighting the relevance of high-yield T7 RNA polymerase transcription for functional RNA studies—including applications in RNA interference experiments and RNA vaccine research.

These internal discussions underscore the translational significance of understanding and manipulating post-transcriptional RNA modifications such as ac4C, especially for optimizing in vitro gametogenesis protocols and developing RNA-based biotechnologies.

Limitations and Transferability

While the reference study provides the first direct evidence for ac4C’s functional role in oocyte maturation, several limitations warrant consideration. The experiments were performed in mouse oocytes and HEK293T cells, and thus, the direct applicability to human oocyte biology or clinical assisted reproductive technologies remains to be established. The identification of TBL3 as an ac4C-binding protein, while promising, is preliminary and requires further validation to confirm its specificity and biological impact in oocytes. Additionally, the study focuses primarily on loss-of-function (NAT10 knockdown) effects; the consequences of ac4C overexpression or manipulation in different developmental contexts are yet to be explored.

The findings, however, are highly transferable to experimental systems that model post-transcriptional regulation, such as in vitro transcription and RNA modification studies. Researchers investigating capped RNA synthesis, biotinylated RNA synthesis, or the impact of epigenetic modifications on RNA stability in various cell types may draw on these results to inform experimental design.

Research Support Resources

For researchers aiming to reproduce or extend studies on RNA modifications, robust in vitro transcription tools are essential. Kits designed for T7 RNA polymerase transcription enable efficient generation of diverse RNA constructs—including those incorporating chemically modified nucleotides or designed for downstream capped RNA synthesis. The HyperScribe™ T7 High Yield RNA Synthesis Kit (SKU K1047) from APExBIO provides a streamlined workflow for high-yield production of various RNA types, supporting applications in RNA interference experiments, RNA vaccine research, and structural-functional studies. This kit may facilitate the synthesis of ac4C-modified transcripts or controls for mechanistic investigations aligned with the approaches described by Xiang et al.